CervoMed Inc.CRVONASDAQ
Loading
SG&A Expenses Over TimeExpanding
Percentile Rank100
3Y CAGR+69.9%
5Y CAGR+10.2%
Studio
Year-over-Year Change

Selling, general, and administrative expenses

3Y CAGR
+69.9%/yr
vs -23.3%/yr prior
5Y CAGR
+10.2%/yr
Recent acceleration
Acceleration
+93.1pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$10.48M+14.4%
2024$9.17M+40.6%
2023$6.52M+204.8%
2022$2.14M-71.3%
2021$7.45M+15.5%
2020$6.44M+33.3%
2019$4.83M-21.6%
2018$6.17M-0.4%
2017$6.19M-27.9%
2016$8.59M-